Standards of Medical Care in Diabetes—2009
By A. Classification. Diabetes Care, 2009
1,122 citations recorded by the source corpus.
Diabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes. These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed. For more detailed information, refer to references 1‐3.
Subfields: Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/208c60f1af5f73fc9df319699e0f82c8dce2fcc8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- Benjamin S. Glicksberg
- Michael J. McShea
- Casey L. Hanley
- Joel T. Dudley
- Adam B. Cohen
- Li Li
- Alain B. Labrique
- Erwin P. Bottinger
Citations in the corpus
- Digital health: a path to validation (2019, methodology): “A digital health product that aims to prevent diabetes mellitus would be measured by standard clinical quality measures, such as clinically validated disease diagnostic criteria,(29) glycemic control, or diabetes-specific complications like stroke and retinal disease.(30) This is important not only ”
- The Lifespan Human Connectome Project in Development: A large-scale study of brain connectivity development in 5–21 year olds (2018, neutral): “For participants providing blood, an additional sample is acquired for assaying Hemoglobin A1c, an indicator of metabolic function that provides information about an individual's risk for obesity and diabetes (American Diabetes Association, 2009; Bunn et al., 1978).”
- Identification of type 2 diabetes subgroups through topological analysis of patient similarity (2015, methodology): “An estimated 29.1 million Americans (9.3% of the population) were estimated to have some form of diabetes in 2012 — up 13% from 2010 — with T2D representing up to 95% of all diagnosed cases ( 1 , 2 ).”